Suchergebnisse - "ГЕНЫ ДЕТОКСИКАЦИИ КСЕНОБИОТИКОВ"

  • Treffer 1 - 14 von 14
Treffer weiter einschränken
  1. 1
  2. 2
  3. 3

    Quelle: General Reanimatology; Том 11, № 3 (2015); 24-38 ; Общая реаниматология; Том 11, № 3 (2015); 24-38 ; 2411-7110 ; 1813-9779 ; 10.15360/1813-9779-2015-3

    Dateibeschreibung: application/pdf

    Relation: https://www.reanimatology.com/rmt/article/view/1462/922; https://www.reanimatology.com/rmt/article/view/1462/984; Yoon Y.S. Respiratory review of 2012: pneumonia. Tuberc. Respir. Dis. (Seoul). 2012; 73 (2): 77–83. http://dx.doi.org/10.4046/trd.2012.73.2.77. PMID: 23166539; Schuetz P., Batschwaroff M., Dusemund F., Albrich W., Bürgi U., Maurer M., Brutsche M., Huber A.R., Müller B. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections; outside of study conditions: a post-study survey. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29 (3): 269—277. http://dx.doi.org/10.1007/s10096-009-0851-0. PMID: 20039090; Мороз В.В., Смелая Т.В., Голубев А.М., Сальникова Л.Е. Генетика и медицина критических состояний: от теории к практике. Общая реаниматология. 2012; 8 (4): 5—12. http://dx.doi.org/10.15360/1813-9779-2012-4-5; Determann R.M., Royakkers A., Wolthuis E.K., Vlaar A.P., Choi G., Paulus F., Hofstra J.J., de Graaff M.J., Korevaar J.C., Schultz M.J. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit. Care. 2010; 14 (1): R1. http://dx.doi.org/ 10.1186/cc8230. PMID: 20055989; Copland I.B., Post M. Understanding the mechanisms of infant respiratory distress and chronic lung disease. Am. J. Respir. Cell Mol. Biol.; 26 (3): 261—265. http://dx.doi.org/10.1165/ajrcmb.26.3.f231.PMID: 11867331; Баранов В.С., Глотов О.С., Баранова Е.В. Геномика старения и предиктивная медицина. Успехи геронтологии. 2010; 23 (3): 329—338. PMID: 21137201; van de Vosse E., van Dissel J.T., Ottenhoff T.H. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 2009; 9 (11): 688—698. http://dx.doi.org/10.1016/S1473-3099(09)70255-5. PMID: 19850227; Brownson R.C., Dodson E.A., Stamatakis K.A., Casey C.M., Elliott M.B., Luke D.A., Wintrode C.G., Kreuter M.W. Communicating evidence-based information on cancer prevention to state-level policy makers. J. Natl. Cancer Inst. 2011; 103 (4): 306—316. http://dx.doi.org/10.1093/jnci/djq529. PMID: 21212381; Davies P.D., Yew W.W., Ganguly D., Davidow A.L., Reichman L.B., Dheda K., Rook G.A. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans. R. Soc. Trop. Med. Hyg. 2006; 100 (4): 291—298. http://dx.doi.org/10.1016/j.trstmh.2005.06.034. PMID: 16325875; Angus D.C., Burgner D., Wunderink R., Mira J.P., Gerlach H., Wiedermann C.J., Vincent J.L. The PIRO concept: P is for predisposition. Crit. Care. 2003; 7 (3): 248—251. PMID: 12793879; Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M.Jr., Musher D.M., Niederman M.S., Torres A., Whitney C.G.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 Suppl 2: S27—S72. http://dx.doi.org/10.1086/511159.PMID: 17278083; Назаренко Г.И., Клейменова Е.Б., Гущина Н.Н. Изучение генетических маркеров и традиционных факторов риска развития ишемической болезни сердца. Рос. мед. вести. 2009; 14 (1): 47—54.; Christie D., Shofer J., Millard S.P., Li E., Demichele-Sweet M.A., Weamer E.A., Kamboh M.I., Lopez O.L., Sweet R.A., Tsuang D. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer’s disease is dependent on the psychosis phenotype. Behav. Brain Funct. 2012; 8: 62. http://dx.doi.org/0.1186/1744-9081-8-62. PMID: 23270420; Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Host genetic risk factors for community-acquired pneumonia. Gene. 2013; 518 (2): 449—456. http://dx.doi.org/ 10.1016/j.gene.2012.10.027. PMID: 23107763; Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia. Int. J. Infect. Dis. 2013; 17 (6): e433—e442. http://dx.doi.org/10.1016/j.ijid.2013.01.005. PMID: 23411129; Мороз В.В., Голубев А.М. Принципы диагностики ранних проявлений острого повреждения легких. Общая реаниматология. 2006; 2 (4): 5—7. http://dx.doi.org/10.15360/1813-9779-2006-4; Rambaldi D., Pece S., Di Fiore P.P. Bioconductor package to estimate proliferation in cell-tracking dye studies. Bioinformatics. 2014; 30 (14): 2060—2065. http://dx.doi.org/10.1093/bioinformatics/btu127. PMID: 24681909; Hamajima N. PCR–CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev. Mol. Diagn. 2001; 1 (1): 119—123. PMID: 11901796; winSTAT.com 2003.1; Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22 (15): 1928—1929. http://dx.doi.org/10.1093/bioinformatics/btl268. PMID: 16720584; Benjamini Y., Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics. 2005; 171 (2): 783—790. http://dx.doi.org/10.1534/genetics.104.036699. PMID: 15956674; Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA. 2003; 100 (16): 9440—9445. PMID: http://dx.doi.org/10.1073/pnas.1530509100.12883005; Abramson J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov. 2011; 8 (1): 1. http://dx.doi.org/10.1186/1742-5573-8-1. PMID: 21288353; Jiang W., Welty S.E., Couroucli X.I., Barrios R., Kondraganti S.R., Muthiah K., Yu L., Avery S.E., Moorthy B. Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J. Pharmacol. Exp. Ther. 2004; 310 (2): 512—519. http://dx.doi.org/10.1124/jpet.103.059766. PMID: 15123765; Jiang W., Couroucli X.I., Wang L., Barrios R., Moorthy B. Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo. Biochem. Biophys. Res. Commun. 2011; 407 (1): 79—85. http://dx.doi.org/10.1016/j.bbrc.2011.02.113. PMID: 21362406; Rotunno M., Yu K., Lubin J.H., Consonni D., Pesatori A.C., Goldstein A.M., Goldin L.R., Wacholder S., Welch R., Burdette L., Chanock S.J., Bertazzi P.A., Tucker M.A., Caporaso N.E., Chatterjee N., Bergen A.W., Landi M.T. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One. 2009; 4 (5): e5652. http://dx.doi.org/10.1371/journal.pone.0005652. PMID: 19479063; Wang S., Chanock S., Tang D., Li Z., Jedrychowski W., Perera F.P. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH- DNA adducts in African American, Dominican and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers Prev. 2008; 17 (2): 405—413. http://dx.doi.org/10.1158/1055-9965. PMID: 18268125; Колесникова Л.И., Баирова Т.А., Первушина О.А. Гены ферментов антиоксидантной системы. Вестник РАМН. 2013; 12: 83—88. PMID: 24741948 29. Smart C.D., Mayton H., Mizubuti E.S., Willmann M.R., Fry W.E. Environmental and genetic factors influencing self-fertility in Phytophthora infestans. Phytopathology. 2000; 90 (9): 987—994. http://dx.doi.org/10.1094 /PHYTO.2000.90.9.987. PMID: 18944524; Zhang B., Beeghly-Fadiel A., Lu W., Cai Q., Xiang Y.B., Zheng Y., Long J., Ye C., Gu K., Shu X.O., Gao Y., Zheng W. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Am. J. Epidemiol. 2011; 173 (10): 1159—1170. http://dx.doi.org/10.1093/aje/kwr004. PMID: 21454829; Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 309—334. PMID: 12540743; Busbee P.B., Rouse M., Nagarkatti M., Nagarkatti P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr. Rev. 2013; 71 (6): 353—369. http://dx.doi.org/10. 1111/nure.12024. PMID: 23731446; Stockinger B. Beyond toxicity: aryl hydrocarbon receptormediated functions in the immune system. J. Biol. 2009; 8 (7): 61. http://dx.doi.org/10.1186/jbiol170. PMID: 19691822; Rohlman D., Pham D., Yu Z., Steppan L.B., Kerkvliet N.I. Aryl hydrocarbon receptor-mediated perturbations in gene expression during early stages of CD4(+) T-cell differentiation. Front. Immunol. 2012; 6 (3): 223. http://dx.doi.org/10.3389/fimmu.2012.00223. PMID: 22888330; Esser C., Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 2015; 67 (2): 259—279. http://dx.doi.org/10.1124/pr.114.009001. PMID: 25657351; Gradman E.H. Evolving understanding of the renin–angiotensin–aldosterone system: pathophysiology and targets for therapeutic intervention. Am. Heart J. 2009; 157: S1—S6.; Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996; 97 (8): 1916—1923. PMID: 8621776; Manzanares W., Dhaliwal R., Jiang X., Murch L., Heyland D.K. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit. Care. 2012; 16 (2): R66. http://dx.doi.org/10.1186/cc11316. PMID: 22534505; Zhou M.S., Schulman I.H., Raij L. Nitric oxide, angiotensin II, and hypertension. Semin. Nephrol. 2004; 24 (4): 366—378. PMID: 15252776 40. Ho R.H., Kim R.B. Transporters and drug therapy: implications for drug disposition and disease. Clin. Pharmacol. Ther. 2005; 78 (3): 260—277. PMID: 16153397; Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008; 38 (7—8): 802—832. http://dx.doi.org/10.1080/00498250701867889. PMID: 18668431; Weng L., Macciardi F., Subramanian A., Guffanti G., Potkin S.G., Yu Z., Xie X. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011; 12: 99. http://dx.doi.org/10.1186/1471-2105-12-99. PMID: 21496265; Braun R., Buetow K. Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data. PLoS Genet. 2011; 7 (6): e1002101. http://dx.doi.org/10.1371/journal.pgen.1002101. PMID: 21695280; Orfanos S.E., Armaganidis A., Glynos C., Psevdi E., Kaltsas P., Sarafidou P., Catravas J.D., Dafni U.G., Langleben D., Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation. 2000; 102 (16): 2011—2018. http://dx.doi.org/10.1161/01.CIR.102.16.2011. PMID: 11034953; Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М., Половников С.Г., Шабанов А.К., Голубев М.А. Сурфактантный протеин А (SP-A) — прогностический молекулярный биомаркер при остром респираторном дистресс-синдроме. Общая реаниматология. 2013; 9 (3): 5—13. http://dx.doi.org/10.15360/1813-9779-2013-3-5; Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М. Новые диагностические кандидатные молекулярные биомаркеры острого респираторного дистресссиндрома. Общая реаниматология. 2014; 10 (4): 6—10. http://dx.doi.org/10.15360/1813-9779-2014-4-6-10; Мороз В.В., Голубев А.М., Кузовлев А.Н., Шабанов А.К., Писарев В.М. Белок клеток Клара (Club cell protein) — новый диагностический кандидатный молекулярный биомаркер при нозокомиальной пневмонии. Общая реаниматология. 2014; 10 (6): 6—14. http://dx.doi.org/10.15360/1813-9779-2014-6-6-14; https://www.reanimatology.com/rmt/article/view/1462

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Additional Titles: МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ МАРКЕРЫ НОЗОКОМИАЛЬНОЙ ПНЕВМОНИИИ ОСТРОГО РЕСПИРАТОРНОГО ДИСТРЕСС-СИНДРОМА

    Quelle: General Reanimatology; Том 11, № 3 (2015); 24-38; Общая реаниматология; Том 11, № 3 (2015); 24-38; 2411-7110; 1813-9779; 10.15360/1813-9779-2015-3

    URL: https://www.reanimatology.com/rmt/article/view/1462/922
    https://www.reanimatology.com/rmt/article/view/1462/984
    https://www.reanimatology.com/rmt/article/view/1462/922
    https://www.reanimatology.com/rmt/article/view/1462/984
    Yoon Y.S. Respiratory review of 2012: pneumonia. Tuberc. Respir. Dis. (Seoul). 2012; 73 (2): 77–83. http://dx.doi.org/10.4046/trd.2012.73.2.77. PMID: 23166539
    Schuetz P., Batschwaroff M., Dusemund F., Albrich W., Bürgi U., Maurer M., Brutsche M., Huber A.R., Müller B. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections
    outside of study conditions: a post-study survey. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29 (3): 269—277. http://dx.doi.org/10.1007/s10096-009-0851-0. PMID: 20039090
    Мороз В.В., Смелая Т.В., Голубев А.М., Сальникова Л.Е. Генетика и медицина критических состояний: от теории к практике. Общая реаниматология. 2012; 8 (4): 5—12. http://dx.doi.org/10.15360/1813-9779-2012-4-5
    Determann R.M., Royakkers A., Wolthuis E.K., Vlaar A.P., Choi G., Paulus F., Hofstra J.J., de Graaff M.J., Korevaar J.C., Schultz M.J. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit. Care. 2010; 14 (1): R1. http://dx.doi.org/ 10.1186/cc8230. PMID: 20055989
    Copland I.B., Post M. Understanding the mechanisms of infant respiratory distress and chronic lung disease. Am. J. Respir. Cell Mol. Biol.
    26 (3): 261—265. http://dx.doi.org/10.1165/ajrcmb.26.3.f231.PMID: 11867331
    Баранов В.С., Глотов О.С., Баранова Е.В. Геномика старения и предиктивная медицина. Успехи геронтологии. 2010; 23 (3): 329—338. PMID: 21137201
    van de Vosse E., van Dissel J.T., Ottenhoff T.H. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 2009; 9 (11): 688—698. http://dx.doi.org/10.1016/S1473-3099(09)70255-5. PMID: 19850227
    Brownson R.C., Dodson E.A., Stamatakis K.A., Casey C.M., Elliott M.B., Luke D.A., Wintrode C.G., Kreuter M.W. Communicating evidence-based information on cancer prevention to state-level policy makers. J. Natl. Cancer Inst. 2011; 103 (4): 306—316. http://dx.doi.org/10.1093/jnci/djq529. PMID: 21212381
    Davies P.D., Yew W.W., Ganguly D., Davidow A.L., Reichman L.B., Dheda K., Rook G.A. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans. R. Soc. Trop. Med. Hyg. 2006; 100 (4): 291—298. http://dx.doi.org/10.1016/j.trstmh.2005.06.034. PMID: 16325875
    Angus D.C., Burgner D., Wunderink R., Mira J.P., Gerlach H., Wiedermann C.J., Vincent J.L. The PIRO concept: P is for predisposition. Crit. Care. 2003; 7 (3): 248—251. PMID: 12793879
    Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M.Jr., Musher D.M., Niederman M.S., Torres A., Whitney C.G.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 Suppl 2: S27—S72. http://dx.doi.org/10.1086/511159.PMID: 17278083
    Назаренко Г.И., Клейменова Е.Б., Гущина Н.Н. Изучение генетических маркеров и традиционных факторов риска развития ишемической болезни сердца. Рос. мед. вести. 2009; 14 (1): 47—54.
    Christie D., Shofer J., Millard S.P., Li E., Demichele-Sweet M.A., Weamer E.A., Kamboh M.I., Lopez O.L., Sweet R.A., Tsuang D. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer’s disease is dependent on the psychosis phenotype. Behav. Brain Funct. 2012; 8: 62. http://dx.doi.org/0.1186/1744-9081-8-62. PMID: 23270420
    Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Host genetic risk factors for community-acquired pneumonia. Gene. 2013; 518 (2): 449—456. http://dx.doi.org/ 10.1016/j.gene.2012.10.027. PMID: 23107763
    Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia. Int. J. Infect. Dis. 2013; 17 (6): e433—e442. http://dx.doi.org/10.1016/j.ijid.2013.01.005. PMID: 23411129
    Мороз В.В., Голубев А.М. Принципы диагностики ранних проявлений острого повреждения легких. Общая реаниматология. 2006; 2 (4): 5—7. http://dx.doi.org/10.15360/1813-9779-2006-4
    Rambaldi D., Pece S., Di Fiore P.P. Bioconductor package to estimate proliferation in cell-tracking dye studies. Bioinformatics. 2014; 30 (14): 2060—2065. http://dx.doi.org/10.1093/bioinformatics/btu127. PMID: 24681909
    Hamajima N. PCR–CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev. Mol. Diagn. 2001; 1 (1): 119—123. PMID: 11901796
    winSTAT.com 2003.1
    Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22 (15): 1928—1929. http://dx.doi.org/10.1093/bioinformatics/btl268. PMID: 16720584
    Benjamini Y., Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics. 2005; 171 (2): 783—790. http://dx.doi.org/10.1534/genetics.104.036699. PMID: 15956674
    Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA. 2003; 100 (16): 9440—9445. PMID: http://dx.doi.org/10.1073/pnas.1530509100.12883005
    Abramson J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov. 2011; 8 (1): 1. http://dx.doi.org/10.1186/1742-5573-8-1. PMID: 21288353
    Jiang W., Welty S.E., Couroucli X.I., Barrios R., Kondraganti S.R., Muthiah K., Yu L., Avery S.E., Moorthy B. Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J. Pharmacol. Exp. Ther. 2004; 310 (2): 512—519. http://dx.doi.org/10.1124/jpet.103.059766. PMID: 15123765
    Jiang W., Couroucli X.I., Wang L., Barrios R., Moorthy B. Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo. Biochem. Biophys. Res. Commun. 2011; 407 (1): 79—85. http://dx.doi.org/10.1016/j.bbrc.2011.02.113. PMID: 21362406
    Rotunno M., Yu K., Lubin J.H., Consonni D., Pesatori A.C., Goldstein A.M., Goldin L.R., Wacholder S., Welch R., Burdette L., Chanock S.J., Bertazzi P.A., Tucker M.A., Caporaso N.E., Chatterjee N., Bergen A.W., Landi M.T. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One. 2009; 4 (5): e5652. http://dx.doi.org/10.1371/journal.pone.0005652. PMID: 19479063
    Wang S., Chanock S., Tang D., Li Z., Jedrychowski W., Perera F.P. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH- DNA adducts in African American, Dominican and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers Prev. 2008; 17 (2): 405—413. http://dx.doi.org/10.1158/1055-9965. PMID: 18268125
    Колесникова Л.И., Баирова Т.А., Первушина О.А. Гены ферментов антиоксидантной системы. Вестник РАМН. 2013; 12: 83—88. PMID: 24741948 29. Smart C.D., Mayton H., Mizubuti E.S., Willmann M.R., Fry W.E. Environmental and genetic factors influencing self-fertility in Phytophthora infestans. Phytopathology. 2000; 90 (9): 987—994. http://dx.doi.org/10.1094 /PHYTO.2000.90.9.987. PMID: 18944524
    Zhang B., Beeghly-Fadiel A., Lu W., Cai Q., Xiang Y.B., Zheng Y., Long J., Ye C., Gu K., Shu X.O., Gao Y., Zheng W. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Am. J. Epidemiol. 2011; 173 (10): 1159—1170. http://dx.doi.org/10.1093/aje/kwr004. PMID: 21454829
    Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 309—334. PMID: 12540743
    Busbee P.B., Rouse M., Nagarkatti M., Nagarkatti P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr. Rev. 2013; 71 (6): 353—369. http://dx.doi.org/10. 1111/nure.12024. PMID: 23731446
    Stockinger B. Beyond toxicity: aryl hydrocarbon receptormediated functions in the immune system. J. Biol. 2009; 8 (7): 61. http://dx.doi.org/10.1186/jbiol170. PMID: 19691822
    Rohlman D., Pham D., Yu Z., Steppan L.B., Kerkvliet N.I. Aryl hydrocarbon receptor-mediated perturbations in gene expression during early stages of CD4(+) T-cell differentiation. Front. Immunol. 2012; 6 (3): 223. http://dx.doi.org/10.3389/fimmu.2012.00223. PMID: 22888330
    Esser C., Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 2015; 67 (2): 259—279. http://dx.doi.org/10.1124/pr.114.009001. PMID: 25657351
    Gradman E.H. Evolving understanding of the renin–angiotensin–aldosterone system: pathophysiology and targets for therapeutic intervention. Am. Heart J. 2009; 157: S1—S6.
    Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996; 97 (8): 1916—1923. PMID: 8621776
    Manzanares W., Dhaliwal R., Jiang X., Murch L., Heyland D.K. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit. Care. 2012; 16 (2): R66. http://dx.doi.org/10.1186/cc11316. PMID: 22534505
    Zhou M.S., Schulman I.H., Raij L. Nitric oxide, angiotensin II, and hypertension. Semin. Nephrol. 2004; 24 (4): 366—378. PMID: 15252776 40. Ho R.H., Kim R.B. Transporters and drug therapy: implications for drug disposition and disease. Clin. Pharmacol. Ther. 2005; 78 (3): 260—277. PMID: 16153397
    Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008; 38 (7—8): 802—832. http://dx.doi.org/10.1080/00498250701867889. PMID: 18668431
    Weng L., Macciardi F., Subramanian A., Guffanti G., Potkin S.G., Yu Z., Xie X. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011; 12: 99. http://dx.doi.org/10.1186/1471-2105-12-99. PMID: 21496265
    Braun R., Buetow K. Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data. PLoS Genet. 2011; 7 (6): e1002101. http://dx.doi.org/10.1371/journal.pgen.1002101. PMID: 21695280
    Orfanos S.E., Armaganidis A., Glynos C., Psevdi E., Kaltsas P., Sarafidou P., Catravas J.D., Dafni U.G., Langleben D., Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation. 2000; 102 (16): 2011—2018. http://dx.doi.org/10.1161/01.CIR.102.16.2011. PMID: 11034953
    Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М., Половников С.Г., Шабанов А.К., Голубев М.А. Сурфактантный протеин А (SP-A) — прогностический молекулярный биомаркер при остром респираторном дистресс-синдроме. Общая реаниматология. 2013; 9 (3): 5—13. http://dx.doi.org/10.15360/1813-9779-2013-3-5
    Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М. Новые диагностические кандидатные молекулярные биомаркеры острого респираторного дистресссиндрома. Общая реаниматология. 2014; 10 (4): 6—10. http://dx.doi.org/10.15360/1813-9779-2014-4-6-10
    Мороз В.В., Голубев А.М., Кузовлев А.Н., Шабанов А.К., Писарев В.М. Белок клеток Клара (Club cell protein) — новый диагностический кандидатный молекулярный биомаркер при нозокомиальной пневмонии. Общая реаниматология. 2014; 10 (6): 6—14. http://dx.doi.org/10.15360/1813-9779-2014-6-6-14